Outset Medical, Inc. (NASDAQ:OM) CEO Leslie Trigg sold 15,000 shares of Outset Medical stock in a transaction dated Friday, September 17th. The stock was sold at an average price of $55.00, for a total value of $825,000.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.
Leslie Trigg also recently made the following trade(s):
- On Wednesday, September 1st, Leslie Trigg sold 20,000 shares of Outset Medical stock. The stock was sold at an average price of $49.16, for a total transaction of $983,200.00.
- On Thursday, July 1st, Leslie Trigg sold 42,500 shares of Outset Medical stock. The stock was sold at an average price of $49.25, for a total transaction of $2,093,125.00.
Shares of OM stock traded down $0.69 during trading on Monday, hitting $54.29. 688,644 shares of the stock traded hands, compared to its average volume of 478,670. The firm has a market capitalization of $2.51 billion and a P/E ratio of -9.80. The company has a debt-to-equity ratio of 0.07, a current ratio of 12.64 and a quick ratio of 11.82. The firm’s fifty day moving average price is $44.42 and its 200-day moving average price is $48.30. Outset Medical, Inc. has a 52-week low of $36.03 and a 52-week high of $66.96.
OM has been the topic of a number of research reports. Morgan Stanley decreased their target price on shares of Outset Medical from $60.00 to $55.00 and set an “equal weight” rating on the stock in a research note on Monday, August 9th. Zacks Investment Research lowered shares of Outset Medical from a “buy” rating to a “hold” rating in a research note on Friday. Finally, Cowen started coverage on shares of Outset Medical in a research report on Wednesday, August 18th. They set an “outperform” rating and a $70.00 price target on the stock. Four research analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Buy” and an average target price of $59.00.
About Outset Medical
Outset Medical, Inc, a medical technology company, develops a hemodialysis system for dialysis. It offers Tablo Hemodialysis System, which comprises of a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings.
Recommended Story: Most Volatile Stocks
Receive News & Ratings for Outset Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Outset Medical and related companies with MarketBeat.com's FREE daily email newsletter.